Bioactive compounds: Definition and assessment of activity

被引：202

作者：

Biesalski, Hans-Konrad ^{[1
]}

Dragsted, Lars Ove ^{[2
]}

Elmadfa, Ibrahim ^{[3
]}

Grossklaus, Rolf ^{[4
]}

Muller, Michael ^{[5
]}

Schrenk, Dieter ^{[6
]}

Walter, Paul ^{[7
]}

Weber, Peter ^{[8
]}

机构：

[1] Univ Hohenheim, Dept Biol Chem & Nutr, D-7000 Stuttgart, Germany

[2] Danish Vet & Food Adm, Inst Food Safety & Nutr, Soborg, Denmark

[3] Univ Vienna, Inst Nutr Sci, Vienna, Austria

[4] Bundesinst Gesundheitlichen Verbraucherschutz & V, Fed Inst Consumer Hlth Protect & Vet Med, Berlin, Germany

[5] Agr Univ Wageningen, Div Human Nutr & Epidemiol, Wageningen, Netherlands

[6] Univ Kaiserslautern, Dept Food Chem & Environm Toxicol, Kaiserslautern, Germany

[7] Univ Basel, Novartis Forsch Stiftung, Inst Biomed Res, Basel, Switzerland

[8] Hoffmann La Roche Vitamins Ltd, Res & Dev Human Nutr & Hlth, Basel, Switzerland

来源：

NUTRITION | 2009年 / 25卷 / 11-12期

关键词：

Biomarker; Bioactive constituents; Nutraceuticals; Health effect; Xenobiotics; Bioavailability; Intake; Phytochemicals; RISK-FACTOR;

D O I：

10.1016/j.nut.2009.04.023

中图分类号：

R15 [营养卫生、食品卫生]; TS201 [基础科学];

学科分类号：

100403 ;

摘要：

Biomarkers and their role in evaluating efficacy and safety were the topic of the 23rd Hohenheim Consensus Meeting at the University of Hohenheim in Stuttgart. Scientists who had published and reviewed scientific and regulatory papers on the topic were invited, among them basic researchers, toxicologists, clinicians, and nutritionists. The participants were presented with 11 questions (in bold font), which were discussed and answered (in italic font) at the workshop, with the aim of summarizing the current state of knowledge on the subject. The explicatory text accompanying the short answers was produced and agreed on after the conference and was backed up by corresponding references. (C) 2009 Published by Elsevier Inc.

引用

页码：1202 / 1205

页数：4

共 14 条

[1] Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part II: Efficacy and safety [J].

Barnes, J .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 55 (04) :331-340

[2] A QUANTITATIVE ASSESSMENT OF PLASMA HOMOCYSTEINE AS A RISK FACTOR FOR VASCULAR-DISEASE - PROBABLE BENEFITS OF INCREASING FOLIC-ACID INTAKES [J].

BOUSHEY, CJ ;

BERESFORD, SAA ;

OMENN, GS ;

MOTULSKY, AG .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (13) :1049-1057

[3]

BRANCA F, 2001, BR J NUTR, V85, P55

[4]

Fung ET, 2000, CURR OPIN MOL THER, V2, P643

[5]

Grossklaus R., 2000, Aktuelle Ernahrungsmedizin, V25, P227

[6] Growth, development and differentiation:: a functional food science approach [J].

Koletzko, B ;

Aggett, PJ ;

Bindels, JG ;

Bung, P ;

Ferré, P ;

Gil, A ;

Lentze, MJ ;

Roberfroid, M ;

Strobel, S .

BRITISH JOURNAL OF NUTRITION, 1998, 80 :S5-S45

[7]

KONG A, 2002, NAT GENET, V6, P10

[8] Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease [J].

Morita, H ;

Taguchi, J ;

Kurihara, H ;

Kitaoka, M ;

Kaneda, H ;

Kurihara, Y ;

Maemura, K ;

Shindo, T ;

Minamino, T ;

Ohno, M ;

Yamaoki, K ;

Ogasawara, K ;

Aizawa, T ;

Suzuki, S ;

Yazaki, Y .

CIRCULATION, 1997, 95 (08) :2032-2036

[9]

SHERLOCK JC, 1995, BIOMARKERS FOOD CHEM, P1

[10] MACROPHAGES, MACROPHAGE FOAM CELLS, AND ECCENTRIC INTIMAL THICKENING IN THE CORONARY-ARTERIES OF YOUNG-CHILDREN [J].

STARY, HC .

ATHEROSCLEROSIS, 1987, 64 (2-3) :91-108

← 1 2 →